-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-09-22
Mbaba and colleagues designed ferrocenyl and organic novobiocin derivatives and compared their in vitro activity against Plasmodium falciparum 3D7 and the HCC38 breast cancer cell line. The study indicates that ferrocene incorporation can improve phenotype-based activity, while also showing why scaffold effects must be separated from target validation and translational claims.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-21
The reference study separates the time-of-day effect on acute endurance performance from the effect of training time on long-term adaptation. In female mice, early-active-phase training produced a larger improvement despite lower absolute workloads, while unchanged liver and muscle glycogen content suggests that training efficiency involved adaptations beyond gross glycogen storage.
-
Dorsomorphin: AMPK and BMP Assay Guide
2026-09-21
Dorsomorphin, also called Compound C, provides reversible control of AMPK activity while also enabling BMP–SMAD pathway interrogation. This practical guide connects hepatocyte metabolism, autophagy regulation, differentiation, and Wnt-linked bone assays with preparation, optimization, and troubleshooting strategies.
-
Glabridin–Gold(I) Complex Enhances Antitumor Immunity
2026-09-20
The reference study develops complex 6d by combining an N-heterocyclic carbene gold(I) center with glabridin to target TrxR and MAPK signaling in liver cancer. Its findings indicate that coordinated redox and immune-microenvironment effects can enhance dendritic-cell maturation, reduce immunosuppressive populations, suppress PD-L1, and promote granzyme B production, while also defining important requirements for mechanistic validation.
-
Tioconazole Workflows for Antifungal Research
2026-09-19
Build more reproducible antifungal assays with Tioconazole, from solvent selection and concentration-response testing to orthogonal ergosterol and membrane-readout validation. This workflow also shows how insights from energy-sensitive DNA-repair research can improve experimental controls without overstating cross-domain evidence.
-
ATG4B Nuclear Translocation and DNA Repair in AML
2026-09-19
The reference study identifies an energy-sensitive ATG4B–PRMT1–MRE11 axis that connects metabolic stress with defective DNA repair and genomic instability in acute myeloid leukemia. Its patient-derived and mouse-model findings suggest that ATG4B inhibition may restrain leukemia progression, while also defining important limits for translating this mechanism beyond AML.
-
lncRNA HITT, ATM, and Cancer Sensitization
2026-09-18
The reference study identifies lncRNA HITT as a direct inhibitor of ATM activation after DNA double-strand breaks. By limiting MRN-dependent ATM recruitment and homologous recombination repair, HITT increases the vulnerability of cancer cells to genotoxic treatment and provides a mechanistic link between noncoding RNA regulation and chemotherapy response.
-
Protease Inhibitor Cocktail for MS-Safe Spike Studies
2026-09-17
Discover how a Protease Inhibitor Cocktail can preserve labile viral and cellular proteins without compromising mass spectrometry. This article connects K4001 sample protection with pH-resolved Lassa virus spike research and practical assay design.
-
Alosetron A3157 for Reliable Cell Assays
2026-09-17
Learn how Alosetron (SKU A3157) can serve as a controlled 5-HT3 receptor pharmacology tool in intestinal proliferation, viability, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical assay controls and the CDC42–YAP–mTOR literature while clearly separating established evidence from research hypotheses.
-
7-dehydro Cholesterol: Applied Research Workflows
2026-09-17
Use 7-dehydro Cholesterol to interrogate DHCR7-dependent sterol flux, UVB-driven vitamin D3 formation, and oxidation-sensitive signaling with controlled, assay-ready workflows. The guide also translates a dhcr7-edited grass carp study into practical controls for lipid, immune, and tissue-response experiments.
-
Disulfiram for Reproducible Cell Viability Assays
2026-09-16
This scenario-based guide explains how Disulfiram, SKU A4015, can support reproducible viability, proliferation, apoptosis, and proteasome studies. It combines practical formulation guidance with evidence from APC-deficient colorectal cancer and established cancer research models.
-
KPT-330 (Selinexor): From Mechanism to Assay Design
2026-09-15
KPT-330 (Selinexor) is a selective CRM1 inhibitor that converts nuclear export biology into a practical framework for cancer research. This guide emphasizes evidence-based assay design, combination testing, and translational interpretation in triple-negative breast cancer models.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-09-15
Capsaicin, also called (E)-Capsaicin, is a TRPV1 ion channel activator and a reversible KDM1A/LSD1 inhibitor. Its research utility spans pain signaling pathway studies, inflammation signaling, chronic dermatitis, gastric cancer, and neuronal models, but assay concentration and biological context determine interpretation.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-14
Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by limiting labile iron. The study connects m6A-dependent RNA regulation with de-SUMOylation, LTF stability, tumor progression, and poor clinical prognosis, providing a mechanistic framework for ferroptosis-sensitizing strategies.
-
Naftifine HCl: Assay Boundaries and Biology
2026-09-14
Naftifine HCl is an allylamine antifungal agent for dissecting sterol-dependent membrane biology. This article connects its mechanism with lessons from WNT5a/GSK3/β-catenin research while defining assay boundaries and practical interpretation standards.